The use of AI in drug discovery has healthcare companies excited, as Milford Investment Analyst Dr Deborah Lambie discovered on her recent visit to the United States. She shared her findings with Heather du Plessis-Allan, including the cost and time-saving benefits of using AI in developing new drugs.